Delivery Order SPE2DB22D1002-SPE2DB25FLDR6
- Not listed
- The Defense Logistics Agency awarded a $8,112 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 100 mg on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,450.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with a completion date of June 16, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government....
- The Defense Logistics Agency awarded a delivery order valued at $3,457.97 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price, competitively awarded delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This firm fixed price delivery order, valued at $2,384.48, was competitively awarded without set-aside restrictions and is scheduled for completion by September 11, 2025. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,253.88 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This competitive delivery order, which was not set-aside for any socioeconomic category, was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, under firm fixed-price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.57 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,442.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50mg tablets. This non-set-aside delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units, with a contract value of $1,908.20. This competitive award, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This firm fixed-price delivery order, issued on June 16, 2025, carries a ceiling value of $2,450.08 and is scheduled for completion by June 17, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order and is...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLDR6Delivery Order
The Defense Logistics Agency awarded a $1,929.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, is a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, including pain management medications such as Nucynta, specialty drugs, vaccines, and medical devices. This delivery order represents a routine fulfillment under the company's prime IDC with DLA, supporting military healthcare operations through competitively awarded, firm fixed price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/16/25 |